Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145329631> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2145329631 endingPage "100" @default.
- W2145329631 startingPage "85" @default.
- W2145329631 abstract "BackgroundUlaritide is a member of the natriuretic peptide family. This hormone exhibits an N-terminal extension by four amino acids compared with atrial natriuretic peptide. Ularitide was shown to exert strong diuretic and natriuretic effects when infused intravenously. Its main action sites are the glomerulum, inducing preglomerular vasodilation and postglomerular vasoconstriction and thereby elevating the glomerular filtration rate, and the tubular system inhibiting Na+-reabsorption. In initial uncontrolled clinical trials, this peptide was shown to have beneficial effects in patients suffering from oliguric acute renal failure.MethodsWe conducted a double-blind. placebo-controlled, multicenter, dosefinding trial recruiting 176 patients randomized into 4 different Ularitide doses groups (U5, U20, U40, and U80 ng/kg/min) and a placebo group (U0). Ularitide/placebo infusion was performed for 5 days with half the originally infused dose on day 5. The primary objective of the study was to test various doses of Ularitide in patients suffering from oliguric acute renal failure to avoid mechanical renal replacement therapy during the first 12 hours.FindingsThe results indicate that Ularitide does not reduce the incidence of mechanical renal replacement therapy compared with placebo-treated patients during the first 12 h of treatment (U0: 36 (20), U5: 35 (11), U20: 36 (9), U40: 28 (8), U80: 41(12), (% (n) (p = 0.87)). Diuresis increased in the Ularitide-treated groups and the placebo group after onset of infusion and did not show any significant difference in the first 12 h collection period (U0: 576, U5: 514, U20: 500, U40: 360, U80: 158 ML/I2h (Median), (p = 0.16)).InterpretationIn summary, the incidence of mechanical renal replacement therapy in critically ill patients suffering from oliguric acute renal failure could not be altered positively by Ularitide administration according to our protocol. Further prospective clinical trials are needed to answer the question whether a different patient collective or a prophylactic administration of Ularitide are more promising approaches in the clinical setting of oliguric acute renal failure." @default.
- W2145329631 created "2016-06-24" @default.
- W2145329631 creator A5009768388 @default.
- W2145329631 creator A5028940295 @default.
- W2145329631 creator A5029366533 @default.
- W2145329631 creator A5035510585 @default.
- W2145329631 creator A5045500957 @default.
- W2145329631 creator A5056652648 @default.
- W2145329631 creator A5060608671 @default.
- W2145329631 creator A5070981585 @default.
- W2145329631 creator A5074994138 @default.
- W2145329631 creator A5079316508 @default.
- W2145329631 date "1999-01-01" @default.
- W2145329631 modified "2023-10-18" @default.
- W2145329631 title "Therapeutic Use of the Natriuretic Peptide Ularitide in Acute Renal Failure" @default.
- W2145329631 cites W1972144668 @default.
- W2145329631 cites W1982915491 @default.
- W2145329631 cites W1995920288 @default.
- W2145329631 cites W2029291925 @default.
- W2145329631 cites W2031656452 @default.
- W2145329631 cites W2047292251 @default.
- W2145329631 cites W2058883587 @default.
- W2145329631 cites W2077828613 @default.
- W2145329631 cites W2078174239 @default.
- W2145329631 cites W2081319320 @default.
- W2145329631 cites W2132266123 @default.
- W2145329631 cites W2139529386 @default.
- W2145329631 cites W2151435234 @default.
- W2145329631 cites W2321262365 @default.
- W2145329631 cites W2412179932 @default.
- W2145329631 cites W2418288050 @default.
- W2145329631 cites W4231271763 @default.
- W2145329631 doi "https://doi.org/10.3109/08860229909066972" @default.
- W2145329631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10048120" @default.
- W2145329631 hasPublicationYear "1999" @default.
- W2145329631 type Work @default.
- W2145329631 sameAs 2145329631 @default.
- W2145329631 citedByCount "55" @default.
- W2145329631 countsByYear W21453296312012 @default.
- W2145329631 countsByYear W21453296312013 @default.
- W2145329631 countsByYear W21453296312022 @default.
- W2145329631 crossrefType "journal-article" @default.
- W2145329631 hasAuthorship W2145329631A5009768388 @default.
- W2145329631 hasAuthorship W2145329631A5028940295 @default.
- W2145329631 hasAuthorship W2145329631A5029366533 @default.
- W2145329631 hasAuthorship W2145329631A5035510585 @default.
- W2145329631 hasAuthorship W2145329631A5045500957 @default.
- W2145329631 hasAuthorship W2145329631A5056652648 @default.
- W2145329631 hasAuthorship W2145329631A5060608671 @default.
- W2145329631 hasAuthorship W2145329631A5070981585 @default.
- W2145329631 hasAuthorship W2145329631A5074994138 @default.
- W2145329631 hasAuthorship W2145329631A5079316508 @default.
- W2145329631 hasConcept C126322002 @default.
- W2145329631 hasConcept C126894567 @default.
- W2145329631 hasConcept C134018914 @default.
- W2145329631 hasConcept C142724271 @default.
- W2145329631 hasConcept C159641895 @default.
- W2145329631 hasConcept C204787440 @default.
- W2145329631 hasConcept C27081682 @default.
- W2145329631 hasConcept C2775915353 @default.
- W2145329631 hasConcept C2778069365 @default.
- W2145329631 hasConcept C2778198053 @default.
- W2145329631 hasConcept C2779547328 @default.
- W2145329631 hasConcept C2779918671 @default.
- W2145329631 hasConcept C71924100 @default.
- W2145329631 hasConceptScore W2145329631C126322002 @default.
- W2145329631 hasConceptScore W2145329631C126894567 @default.
- W2145329631 hasConceptScore W2145329631C134018914 @default.
- W2145329631 hasConceptScore W2145329631C142724271 @default.
- W2145329631 hasConceptScore W2145329631C159641895 @default.
- W2145329631 hasConceptScore W2145329631C204787440 @default.
- W2145329631 hasConceptScore W2145329631C27081682 @default.
- W2145329631 hasConceptScore W2145329631C2775915353 @default.
- W2145329631 hasConceptScore W2145329631C2778069365 @default.
- W2145329631 hasConceptScore W2145329631C2778198053 @default.
- W2145329631 hasConceptScore W2145329631C2779547328 @default.
- W2145329631 hasConceptScore W2145329631C2779918671 @default.
- W2145329631 hasConceptScore W2145329631C71924100 @default.
- W2145329631 hasIssue "1" @default.
- W2145329631 hasLocation W21453296311 @default.
- W2145329631 hasLocation W21453296312 @default.
- W2145329631 hasOpenAccess W2145329631 @default.
- W2145329631 hasPrimaryLocation W21453296311 @default.
- W2145329631 hasRelatedWork W1980957264 @default.
- W2145329631 hasRelatedWork W2000526551 @default.
- W2145329631 hasRelatedWork W2002038679 @default.
- W2145329631 hasRelatedWork W2036863687 @default.
- W2145329631 hasRelatedWork W2050825966 @default.
- W2145329631 hasRelatedWork W2161501502 @default.
- W2145329631 hasRelatedWork W2165498777 @default.
- W2145329631 hasRelatedWork W2212154849 @default.
- W2145329631 hasRelatedWork W2283093578 @default.
- W2145329631 hasRelatedWork W2473470765 @default.
- W2145329631 hasVolume "21" @default.
- W2145329631 isParatext "false" @default.
- W2145329631 isRetracted "false" @default.
- W2145329631 magId "2145329631" @default.
- W2145329631 workType "article" @default.